elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q59273721-1A9291CF-2434-45E9-ACC3-2571FF1C38DC
Q59273721-1A9291CF-2434-45E9-ACC3-2571FF1C38DC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59273721-1A9291CF-2434-45E9-ACC3-2571FF1C38DC
Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening†
P2860
Q59273721-1A9291CF-2434-45E9-ACC3-2571FF1C38DC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59273721-1A9291CF-2434-45E9-ACC3-2571FF1C38DC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
295d4fb406280a1ad5e2fbda900d4d235a467a4b
P2860
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.